AAminove
Back to library

AOD-9604

Animal / preclinical

Also known as: hGH fragment 176-191

Metabolic / fat-lossFat loss (claimed)

Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.

Overview

A modified fragment of human growth hormone marketed for fat loss. Human trials did not demonstrate meaningful weight loss.

Mechanism

A GH C-terminal fragment proposed to stimulate lipolysis without GH's growth effects; efficacy unproven in humans.

Evidence

Animal / preclinicalWhat does this mean?

Weak: human obesity trials were largely negative for weight loss. Claims are not supported.

Community-reported information

Community reports vary. Anecdotal and unvalidated; general information only.

General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.

Half-life

Short.

Storage

Lyophilised: refrigerate. Reconstituted: refrigerate.

Commonly reported side effects

  • Not well characterised
  • Injection-site reactions reported anecdotally

Legal status by region

  • USNot FDA-approved; not a lawful supplement ingredient.

Legal status changes over time; verify locally before relying on this.

Citations